High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
about
Clinical impact of occult hepatitis B virus infection in immunosuppressed patientsUpdate on occult hepatitis B virus infectionGenotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern AfricaMaternal hepatitis B and infant infection among pregnant women living with HIV in South Africa.Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern IndiaPrevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women.Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected GambiansHIV-HBV coinfection among South African patients receiving antiretroviral therapy.The prevalence of hepatitis B co-infection in a South African urban government HIV clinic.Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South AfricaEpidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: high prevalence of occult hepatitis B and F3 subgenotype dominanceOccult hepatitis B virus coinfection in HIV-positive African migrants to the UK: a point prevalence study.Prevalence of hepatitis B surface antigen (HBsAg) and its risk factors among individuals visiting Goba General Hospital, South East Ethiopia, 2012.Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia.Occult hepatitis B virus infection: A major concern in HIV-infected patients: Occult HBV in HIV.Unusual presentation of hepatitis B serological markers in an Amerindian community of Venezuela with a majority of occult cases.HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review ArticleVariability of the preC/C region of hepatitis B virus genotype A from a South African cohort predominantly infected with HIV.Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variantsMutations associated with occult hepatitis B in HIV-positive South AfricansPrevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients.Hepatitis B virus burden in developing countries.Occult Hepatitis B (OBH) in Clinical Settings.Hepatitis B virus / human immunodeficiency virus co-infection and its hepatocarcinogenic potential in sub-saharan black africans.Hepatocellular cancer in HIV-infected individuals: tomorrow's problem?Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania.Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART eraCharacterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.Liver Fibrosis and Hepatitis B Coinfection among ART Naïve HIV-Infected Patients at a Tertiary Level Hospital in Northwestern Tanzania: A Cross-Sectional StudyFunctional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women.Occult hepatitis B virus infection among human immunodeficiency virus-infected patients with isolated hepatitis B core antibody in Isfahan, Iran.Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis.Nosocomial outbreak of hepatitis B virus infection in a pediatric hematology and oncology unit in South Africa: Epidemiological investigation and measures to prevent further transmission.Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients.Active co-infection with HBV and/or HCV in South African HIV positive patients due for cancer therapy.Sustained favourable HIV viral load response in South African patients during concomitant HAART and cancer therapy.Characterization of overt and occult hepatitis B virus infection among HTLV-1 positive healthy carriers in the Northeast of Iran; AN HTLV-I endemic area.Prevalence of occult hepatitis B virus infection in a cohort of HIV-positive patients resident in Sicily, Italy.
P2860
Q27006996-C2B4B901-061E-4EF7-B5A5-3B629672235EQ28070317-9E43B1E9-8751-4E38-BD10-568D562E89DFQ28484102-9FE14FC4-BB47-4CA7-B026-EEC0A5898A2DQ33655929-E073F087-CAED-48DA-BE67-460453AECF99Q33773235-9C1BEBE4-3036-4B1C-874B-7514DE3F4F38Q34080934-AD7200F5-8F7B-4484-83E5-E623652295BEQ34174489-AD5DB295-2C7E-4CBC-AEF0-D72B8C9D9AA6Q34401948-055E6527-FA29-4725-A49B-8CC2C5C06C88Q34432918-3FFF063E-9728-4607-92F1-26773E4FD853Q34437586-D11564C7-E5D8-4581-9C1D-F9D79CEBE7A3Q34468872-9EB32363-1332-4FB8-901E-E218B5C883D3Q34612595-83CFA44C-F0F9-4E53-900D-E5AEB9E305FDQ34629219-131A4D3A-268F-406C-AAE7-51AFCC327101Q34636480-8E4E8234-0F55-46A6-AB7D-2A5845BCD830Q34695618-46216B2C-180E-467F-9925-6B69B69680CCQ35507274-69AB28A6-3C41-4F4E-9A3F-050358EDD76FQ35658373-97C63288-0EE4-4F8E-BD7E-6695E34C2736Q36022260-F2E2BF02-95FA-4785-A20C-7637BBD4205EQ36027172-D6D9E8AB-276F-444B-9564-6F541EA8867CQ36028735-DE48DED3-8B23-4CDE-8F15-7E77752549B0Q36035578-AFEE1CF2-52DC-4008-8C69-508620D5C860Q36131256-E550465E-5DA5-47E4-AFC7-602627E5265CQ36269649-A955FBA9-F207-4D75-B4BA-A311B4AF62E9Q36328982-74569008-4F6D-4B3E-BC84-9288922F422FQ36407167-552A5CD0-8FE5-4F5A-BEDF-22C8454E0398Q36668229-D4A42D4E-8000-415C-9C21-B466FAAEFAD7Q37059321-2BDFBC7E-3C06-4DD7-845B-1724D60E204FQ37113540-4862D55A-550E-4C1C-97A7-A00C9BFEEC9BQ37686490-6AE3B786-197B-47A9-81E6-B556A792D2AFQ38615081-057E0F68-E59E-4E13-B04E-DDE8EBD0006EQ38782188-036112BF-3DDC-46CE-BBE6-87B9344CD276Q38926501-38EC2870-43C3-4623-A7B7-E51132306B6CQ39134503-D053932B-F6EA-4118-BFB3-324E5156499BQ41128836-5317ECC4-6E63-435F-AD61-972BCB505505Q41182375-1856D7CD-E7BF-49FC-9216-A5DC72F66217Q41925761-ED86F491-D79D-4B49-A115-0C51A34E61FBQ42197952-3D9B905D-313C-4714-84BC-11363ED18BE9Q42197959-D0BCE1C2-10F7-4E07-BC05-79C4850C72DCQ42199389-5415B074-AB86-4FF8-80A1-A3C2A8811E71Q42267396-A3902282-1329-4C98-B0DC-58336D5CAFDF
P2860
High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
High risk of occult hepatitis ...... ve patients from South Africa.
@en
High risk of occult hepatitis ...... ve patients from South Africa.
@nl
type
label
High risk of occult hepatitis ...... ve patients from South Africa.
@en
High risk of occult hepatitis ...... ve patients from South Africa.
@nl
prefLabel
High risk of occult hepatitis ...... ve patients from South Africa.
@en
High risk of occult hepatitis ...... ve patients from South Africa.
@nl
P2093
P1476
High risk of occult hepatitis ...... ve patients from South Africa.
@en
P2093
Johannes M Ngobeni
Lucky M Moropeng
M Jeffrey Mphahlele
P356
10.1016/J.JCV.2005.04.003
P577
2006-01-01T00:00:00Z